Moleculin Biotech, Inc.

NASDAQ:MBRX

2.36 (USD) • At close October 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015
Operating Activities:
Net Income -29.769-29.025-15.894-17.355-13.205-11.876-9.805-3.926-0.748
Depreciation & Amortization 0.1270.130.1640.20.1990.0680.0180.0060
Deferred Income Tax -0.4030-6.728-2.34-4.0630-1.38700
Stock Based Compensation 1.9842.2752.3731.681.5371.140.7070.4110
Change In Working Capital 1.6220.2241.038-0.041-2.1421.610.542-0.2560.323
Accounts Receivables 000000000
Inventory 000000000
Accounts Payables 0.4030.7310.235-1.0240.9070.4360.411-41.1280
Other Working Capital 1.219-0.5070.8030.983-3.0491.1740.13140.8720.323
Other Non Cash Items 2.338-1.2430.0960.0850.476-3.1452.6010.4240.002
Operating Cash Flow -24.101-27.639-18.951-17.771-17.198-12.203-7.324-3.765-0.424
Investing Activities:
Investments In Property Plant And Equipment -0.124-0.067-0.019-0.376-0.052-0.417-0.028-0.0210
Acquisitions Net 0000.0020.00100-0.10
Purchases Of Investments 000000000
Sales Maturities Of Investments 000000000
Other Investing Activites 000000000
Investing Cash Flow -0.124-0.067-0.019-0.374-0.051-0.417-0.028-0.1210
Financing Activities:
Debt Repayment 0000000-0.47-0.45
Common Stock Issued 4.166074.68422.56120.85412.0256.0719.170.002
Common Stock Repurchased -0-0-0-000000
Dividends Paid 000000000
Other Financing Activities 0.005-0.0230.04-0.0120.0210.023.9880.1650.001
Financing Cash Flow 0.005-0.02374.72422.5490.02112.04510.0598.8650.452
Other Information:
Effect Of Forex Changes On Cash -0.021-0.029-0.0240.034-0.004-0.005000
Net Change In Cash -19.595-27.75855.734.4383.601-0.582.7074.9790.028
Cash At End Of Period 23.5543.14570.90315.17310.7357.1347.7145.0070.028